Novel GPCR GAVE10 polypeptides, proteins and nucleic acid molecules are
provided. GAVE10, recombinant expression vectors, host cells
incorporating GAVE10 expression vectors and non-human transgenic animals
into which a GAVE10 gene has been introduced or disrupted are taught.
Diagnostic, screening and therapeutic methods utilizing compositions of
the invention also are provided.